| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |